Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Milwaukee at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
The purpose of this study is to determine if combination treatment with cemiplimab, motixafortide, gemcitabine, and nab-paclitaxel is effective in decreasing the size of the tumor(s), if it will prolong life in patients, and if it's safe. The treatment consists of standard chemotherapy (gemcitabine and nab-paclitaxel) which is FDA approved and is standard treatment for patients with pancreatic adenocarcinoma. Participants will receive immunotherapy (cemiplimab) which activates the body's immune
Sponsor: Gulam Manji
Check if you qualify for this pancreatic cancer clinical trial in Milwaukee, WI
If you're searching for pancreatic cancer treatment options in Milwaukee, WI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Milwaukee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.